7
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Isotype and Immunoglobulin Subclass Distribution of eye Muscle Membrane Reactive Antibodies in the Serum of Patients with Thyroid-Associated Ophthalmopathy as Detected in Western Blotting

, , , , &
Pages 57-63 | Accepted 30 Jan 1991, Published online: 07 Jul 2009

References

  • Salvi M, Zhang Z ‐G, Haegert D, Woo M, Liberman A, Cadarso L, Wall J R. Patients with endocrinc ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clip Endocrinol Metab. 1990; 70: 89–94
  • Salvi M, Fukazawa H, Hiromatsu Y, Triller H, Bernard N, How J, Wall J R. Role of autoantibodies in the pathogenesis of endocrine autoimmune disorders and in their association. Endocrine Reviews 1988; 9: 450–466
  • Kodama K, Sikorska H, Bandy‐Dafoe P, Baylcy R, Wall J R. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves' ophthalmopathy. Lancet. 1982; ii: 1353–1356
  • Kendall‐Taylor P, Atkinson S, Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro‐orbital and thyroid autoimmunity. Brit Med J. 1984; 288: 1183–1186
  • Bemetz U, Moncayo R, Scherbaum W, Frisch H, Bordenhoop K, Schleusener H, Pfeifler E F. Detection of IgG an IgM antibodies directed against eye and peripheral muscle prepatations in juvenile and adult patients with Graven' dixase and in patients with hyperthyroidism. Proc Intl Symposium on Thyroid Autoimmunity. Elsevier, Amsterdam 1986, (Abstr
  • Mengistu M, Laryea E, Miller A, Wall J R. Clinical significance of a new autoantibody against a human eye muscle soluble antigen detected by immunofluorescence. Clin Exp Immunol. 1986; 65: 19–27
  • Faryna M, Nauman T, Gordos A. Measurement of autoantibodies against human eye muscle plasma membrane in Graves' ophthalmopathy. Brit Med J. 1985; 290: 191–192
  • Hiromatsu Y, Fukazawa H, How J, Wall J R. Antibody‐dependent cell‐mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy ‐ roles of class 11 MHC antigen expression and interferon‐γ action on effector and target cells. Clin Exp Immunol. 1987; 70: 593–603
  • Wang P W, Hiromatsu Y, Laryea E A, Wosu L, How J S, Wall J R. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. J Clin Endocrinol Metab. 1986; 63: 316–320
  • Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall J R. A thyroid cytotoxic antibody that cross‐reacts with an eye muscle cell surface antigen may be the cause of thyroid‐associated ophthalmopathy. J. Clin Endocrinol Metab. 1988; 67: 565–570
  • Salvi M, Miller A, Wall J R. Human orbital tissue and thyroid membrane express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid‐associated ophthalmopathy. FEBS Let. 1988; 232: 135–139
  • Salvi M, Bernard N, Miller A, Zhang Z ‐G, Gardini E, Wall J R. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid‐associated ophthalmopathy. Thyroid.
  • Kapusta M, Salvi M, Triller H, Gardini E, Bernard N, Wall J R. Eye muscle membrane reactive antibodies are not detected in the serum or immunoglobulin fraction of patients with thyroid‐associated ophthalmopathy using an ELISA and crude membranes. Autoimmunity. 1990; 7: 33–40
  • Laemmli U K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680–684
  • Yount W J, Hong R, Seligman M, Good R A, Kunkel H G. Imbalance of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia. J Clin Invest. 1970; 49: 1957–1966
  • Schur P H. Human gamma‐G subclass. Progress in Clinical Immunology, R S Schwartz. Grune and Stratton, New York 1972; vol. 1: 171
  • French M A H, Harrison G. Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol. 1984; 56: 473–480
  • Virella G, Howard A, Cherrington J. Distribution of heavy chain subclasses of immunoglobulin G in normal IgG and residual IgG from hypogammaglobulinaemic sera. Clin Exp Immunol. 1970; 7: 671–680
  • Shakib F, Stanworth D R. Human IgG subclasses in health and disease (A Review) Part I. Ric Clin Lab. 1980; 10: 561–580
  • Lefvert A K, Bergstrom K. Immunoglobulin in Myasthenia gravis: effect of human lymph IgG3 and F(ab)2 fragments on a cholinergic receptor preparation from Torpedo marmorata. Eur J Clin Invest. 1977; 7: 115–119
  • Fulpius B W, Miskin R, Reich E. Antibodies from myasthenia patients that compete with cholinergic agents for binding to nicotinic receptors. Proc Natl Acad Sci USA. 1980; 77: 4326–4330
  • Carruthers J A, Ewing A R. Herpes gestationis: studies on the binding characteristics, activity and pathogenic significance of the complement fixing factor. Clin Exp Immunol. 1978; 31: 38–44
  • Sams W M, Schur P H. Studies of the antibodies in pemphigoid and pemphigus. J Lab Clin Med. 1973; 82: 249–254
  • Riggione O, Stokes R P, Thompson R A. Predominance of IgG3 subclass antibodies in primary biliary cirrhosis. Brit Med J. 1983; 286: 1015–1016
  • Weetman A P, Black C M, Cohen S B, Tomlinson R, Banga J P, Reimer C B. Affinity purification of IgG subclasses and distribution of thyroid auto‐antibody reactivity in Hashimoto's thyroiditis. Scan J Immunol. 1989; 30: 73–82
  • Kotani T, Umeki K, Matsunaga S, Kato E, Ohtaki S. Detection of autoantibodies to thyroid peroxidase in autoimmune thyroid diseases by microenzyme‐linked immunosorbent assay and immunoblotting. J Clin Endocrinol Metab. 1986; 62: 928–933
  • Jansson R, Thompson P M, Clark F, McLachlan S M. Association between thyroid microsomal antibodies of subclass IgG1 and hypothyroidism in autoimmune postpartum thyroiditis. Clin Exp Immunol. 1986; 63: 80–86
  • Aalberse R C, Van der Gaag R, Van Leeuwen J. Serologic aspects of IgG, antibodies. I. Prolonged immunization results in an IgG4 restricted response. J Immunol. 1983; 130: 722–726
  • Doi T, Mayumi M, Karatzu K, Suchiro F, Hamashima Y. Distribution of IgG subclasses in membraneous nephropathy. Clin Exp Immunol. 1984; 58: 57–62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.